Text Size
15 studies found for:    Open Studies | "Poxviridae Infections"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Poxviridae Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
Condition: Smallpox
Intervention: Biological: ACAM2000® smallpox vaccine
2 Recruiting Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)
Condition: AIDS
Interventions: Biological: DNA vaccine;   Biological: DNA vaccine prime with the addition of electroporation;   Biological: rTV boost at week 16;   Biological: rTV boost at week 24;   Biological: rTV boost at week 32
3 Recruiting Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults
Conditions: HIV Seronegativity;   HIV Preventive Vaccine
Interventions: Biological: MVA-C + gp140/MF59;   Biological: DNA-C2 + MVA-C;   Biological: DNA-C2 + MVA-C + gp140/MF59
4 Recruiting A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Condition: Smallpox
Interventions: Biological: IMVAMUNE;   Other: Placebo
5 Recruiting A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects
Condition: Smallpox
Interventions: Biological: LF formulation of IMVAMUNE®;   Biological: FD formulation of IMVAMUNE®
6 Recruiting Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
Conditions: Colorectal Carcinoma;   CRC
Interventions: Biological: JX-594;   Drug: Irinotecan
7 Recruiting Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma
Condition: Lung Cancer
Intervention: Biological: GL-ONC1
8 Unknown † Safety and Efficacy of CJ-50300 in Healthy Volunteers
Condition: Smallpox
Intervention: Biological: smallpox vaccine CJ-50300
9 Recruiting A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis
Condition: Peritoneal Carcinomatosis
Intervention: Biological: GL-ONC1
10 Not yet recruiting Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
Condition: Smallpox
Intervention: Biological: IMVAMUNE®
11 Recruiting Immune Responses to Smallpox Vaccination
Condition: Smallpox Vaccine
Intervention:
12 Recruiting Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)
Condition: Smallpox
Intervention:
13 Recruiting Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer
Condition: Cancer of Head and Neck
Intervention: Biological: GL-ONC1
14 Unknown † Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum
Condition: Molluscum Contagiosum
Interventions: Drug: Hydroxide Potassium;   Drug: Placebo
15 Recruiting A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate Cancer
Condition: Prostate Cancer Metastatic
Interventions: Biological: PROSTVAC-V;   Biological: PROSTVAC-F;   Drug: GM-CSF;   Other: GM-CSF Placebo;   Biological: Placebo
To Top

† Indicates status has not been verified in more than two years